logo

For the Inventor, By the Inventor

Gujarat, India

Mayank Ghanshyambhai Dave

This inventor holds 9 USPTO granted patents and 5 published patent applications and 7 EPO patents. Top assignee: Cadila Healthcare Limited. Active years: 2010-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mayank Ghanshyambhai Dave. Retrieved from https://idiyas.com/inventor/mayank-ghanshyambhai-dave

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • Ahmedabad, IN (2011 - 2013)
  • Gujarat, IN (2010 - 2015)

Company Filing History:

goldMedal9 out of 131 
 
Cadila Healthcare Limited
 patents

Years Active: 2010-2015

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 9108972 - Salts of DPP-IV inhibitor (2015-08-18),
2. 8907090 - Processes for preparing different forms of (S)-(+)-Clopidogrel bisulfate (2014-12-09),
3. 8754207 - Process for the preparation of rapamycin derivatives (2014-06-17),
4. 8476437 - Process for preparation of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro [1,2,4]-triazolo[4,3-a]pyrazin-7(8H)-yl]-l-(2,4,5-trifluorophenyl)butan-2-amine and new impurities in preparation thereof (2013-07-02),
5. 8053579 - Salts of clopidogrel and process for preparation (2011-11-08),
6. 7994322 - Processes for the preparation of different forms of (S)-(+)-clopidogrel besylate (2011-08-09),
7. 7960550 - Process for preparing (S)-(+)-clopidogrel base and its salts (2011-06-14),
8. 7872019 - Polymorphs and amorphous form of (S)-(+)-clopidogrel bisulfate (2011-01-18),
9. 7732608 - Salts of clopidogrel and process for preparation (2010-06-08),

Title: Innovations of Mayank Ghanshyambhai Dave

Introduction

Mayank Ghanshyambhai Dave is a prominent inventor based in Gujarat, India. He has made significant contributions to the field of pharmaceuticals, holding a total of nine patents. His work focuses on the development of innovative compounds and processes that enhance therapeutic efficacy.

Latest Patents

One of his latest patents involves the invention of new salts of a DPP-IV inhibitor. This invention discloses new salts of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]-triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine, including gentisate, adipate, and trifluoroacetic acid salts. The invention also describes new crystalline and amorphous forms of this compound. Additionally, he has developed novel crystalline salt forms of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]-triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine hydrochloride, along with novel crystalline and amorphous salt forms of besylate and processes for their preparation and isolation. Furthermore, he has improved processes for preparing different forms of (S)-(+)-Clopidogrel bisulfate, including hydrated forms and form-I and form-II.

Career Highlights

Mayank Ghanshyambhai Dave is currently associated with Cadila Healthcare Limited, a leading pharmaceutical company. His innovative work has contributed to the advancement of drug formulations and therapeutic options in the healthcare sector.

Collaborations

He has collaborated with notable coworkers such as Bipin Pandey and Braj Bhushan Lohray, enhancing the research and development efforts within his team.

Conclusion

Mayank Ghanshyambhai Dave's contributions to pharmaceutical innovations through his patents and collaborative efforts highlight his significant role in advancing healthcare solutions. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…